{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=54", "query": { "intervention": "Control Comparator", "page": 54 }, "page_size": 10 }, "pagination": { "page": 54, "page_size": 10, "total_count": 1670, "total_pages": 167, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=55&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=53&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T12:37:53.554Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00784875", "title": "An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Insomnia", "Secondary Insomnia" ], "interventions": [ { "name": "LY2624803", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "zolpidem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 643, "start_date": "2008-10", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2012-02-29", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 49, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Mesa, Arizona + 46 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00784875" }, { "nct_id": "NCT05925634", "title": "Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Myocardial Infarction", "Coronary Artery Bypass", "Percutaneous Coronary Intervention", "Heart Failure", "Cardiac Valve Surgery" ], "interventions": [ { "name": "RPE (usual care)", "type": "BEHAVIORAL" }, { "name": "GXT+THHR (intervention)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Baystate Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "60 Years to 99 Years" }, "enrollment_count": 320, "start_date": "2023-08-10", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-08-04", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 2, "location_summary": "Springfield, Massachusetts • Detroit, Michigan", "locations": [ { "city": "Springfield", "state": "Massachusetts" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05925634" }, { "nct_id": "NCT01979601", "title": "Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "LGT209", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 74, "start_date": "2010-12", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2013-12-10", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 2, "location_summary": "Miami Gardens, Florida • Fargo, North Dakota", "locations": [ { "city": "Miami Gardens", "state": "Florida" }, { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01979601" }, { "nct_id": "NCT00784719", "title": "A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Dry Eye Syndromes" ], "interventions": [ { "name": "CP-690,550", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "CP-690,550 Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 327, "start_date": "2008-11", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2013-04-09", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 27, "location_summary": "Chandler, Arizona • Peoria, Arizona • Phoenix, Arizona + 22 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Artesia", "state": "California" }, { "city": "Centennial", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00784719" }, { "nct_id": "NCT03346057", "title": "Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Reversal of Neuromuscular Blockade" ], "interventions": [ { "name": "Sugammadex 2 mg/kg", "type": "DRUG" }, { "name": "Sugammadex 4 mg/kg", "type": "DRUG" }, { "name": "Sugammadex 16 mg/kg", "type": "DRUG" }, { "name": "Neostigmine + Glycopyrrolate", "type": "DRUG" }, { "name": "Rocuronium", "type": "DRUG" }, { "name": "Vecuronium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 344, "start_date": "2017-12-20", "completion_date": "2019-09-04", "has_results": true, "last_update_posted_date": "2020-10-08", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Loma Linda, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03346057" }, { "nct_id": "NCT01850381", "title": "Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "GM608", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genervon Biopharmaceuticals, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 6, "start_date": "2013-06", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2019-08-08", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01850381" }, { "nct_id": "NCT03909165", "title": "Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Neuromuscular Blockade" ], "interventions": [ { "name": "Sugammadex 2 mg/kg", "type": "DRUG" }, { "name": "Sugammadex 4 mg/kg", "type": "DRUG" }, { "name": "Neostigmine + Glycopyrrolate", "type": "DRUG" }, { "name": "Neostigmine + Atropine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "2 Years", "sex": "ALL", "summary": "1 Day to 2 Years" }, "enrollment_count": 145, "start_date": "2019-07-23", "completion_date": "2023-09-21", "has_results": true, "last_update_posted_date": "2025-07-25", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 7, "location_summary": "Palo Alto, California • Miami, Florida • Oklahoma City, Oklahoma + 4 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03909165" }, { "nct_id": "NCT01796977", "title": "Using A Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Reconstructive Breast Surgery" ], "interventions": [ { "name": "OxyGenesys Dissolved Oxygen Dressing", "type": "DEVICE" }, { "name": "Standard Gauze Dressing", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Halyard Health", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "FEMALE", "summary": "21 Years and older · Female only" }, "enrollment_count": 27, "start_date": "2012-12", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2016-02-17", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 7, "location_summary": "Chicago, Illinois • St Louis, Missouri • Great Neck, New York + 3 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Great Neck", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01796977" }, { "nct_id": "NCT06001177", "title": "A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Celiac Disease", "Coeliac Disease" ], "interventions": [ { "name": "KAN-101", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 55, "start_date": "2023-12-13", "completion_date": "2025-01-13", "has_results": true, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 6, "location_summary": "Colorado Springs, Colorado • Hialeah Gardens, Florida • Miami, Florida + 3 more", "locations": [ { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Hialeah Gardens", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Wichita", "state": "Kansas" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06001177" }, { "nct_id": "NCT03397771", "title": "DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Urinary Incontinence" ], "interventions": [ { "name": "Litoxetine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ixaltis SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 84, "start_date": "2018-04-03", "completion_date": "2019-05-30", "has_results": true, "last_update_posted_date": "2020-06-11", "last_synced_at": "2026-10-25T12:37:53.554Z", "location_count": 1, "location_summary": "Williamsville, New York", "locations": [ { "city": "Williamsville", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03397771" } ] }